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Abstract 
Maternal infection/inflammation represents one of the most important factors 
involved in the etiology of brain injury in newborns. We investigated the modulating effect of 
prenatal melatonin on the neonatal brain inflammation process resulting from maternal 
intraperitoneal (i.p.) lipopolysaccharide (LPS) injections. LPS (300 μg/kg) was administered 
to pregnant rats at gestational days 19 and 20. Melatonin (5 mg/kg) was administered i.p. at 
the same time as LPS. Melatonin counteracted the LPS sensitization to a second ibotenate-
induced excitotoxic insult performed on postnatal day (PND) 4. As melatonin succeeded in 
reducing microglial activation in neonatal brain at PND1, pathways previously implicated in 
brain inflammation regulation such as endoplasmic reticulum (ER) stress, autophagy and 
silent information regulator 1 (SIRT1), a melatonin target, were assessed at the same time-
point in our experimental groups. Results showed that maternal LPS administrations resulted 
in an increase in CHOP and Hsp70 protein expression and eIF2α phosphorylation, indicative 
of activation of the unfolded protein response consequent to ER stress, and a slighter decrease 
in the autophagy process, determined by reduced lipidated LC3 and increased p62 expression. 
LPS-induced inflammation also reduced brain SIRT1 expression and affected the expression 
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of miR-34a, miR146a and miR-126. All these effects were blocked by melatonin. Cleaved-
caspase-3 apoptosis pathway did not seem to be implicated in the noxious effect of LPS on 
the PND1 brain. We conclude that melatonin is effective in reducing maternal LPS-induced 
neonatal inflammation and related brain injury. Its role as a prophylactic/therapeutic drug 
deserves to be investigated by clinical studies. 
 
KEYWORDS 
melatonin, inflammation, SIRT1, endoplasmic reticulum stress, autophagy, miRNA, neonatal 
brain injury 
 
1 | INTRODUCTION 
Systemic inflammation/infection represents one of the main events in the pathogenesis 
of brain injury in both term and preterm infants.1 Preterm infants frequently show high 
concentrations of pro-inflammatory cytokines in amniotic fluid and fetal blood, particularly 
those with chorioamniotitis1 and vasculitis.2 These pathological conditions are clearly 
associated with an increased risk for intra-partum cerebral failure, cerebral palsy and 
permanent neurodevelopmental handicaps.1  
In recent years, considerable evidence has demonstrated that inflammation is linked to 
endoplasmic reticulum (ER) stress, characterized by the accumulation of unfolded proteins in 
the ER that triggers a series of signal-transduction events known as unfolded protein response 
(UPR). The aim of UPR is to overcome the stressful condition and restore ER homeostasis,3 
and is initiated by the activation of three specific ER stress sensors: PERK (PKR-like ER 
kinase), ATF-6 (activating transcription factor 6) and IRE1 (inositol-requiring enzyme 1).  
Through the UPR, cells inhibit translation, reverse translocation, and activate ER-specific 
ubiquitination enzymes (the ERAD response).3 The UPR also leads to the activation of an 
inflammatory response through the induction of inflammatory cytokines.4 This is triggered by 
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both the suppression of IkB translation and subsequent NFkB activation,5 and activation of 
the AP-1 (activator protein-1) pathway.6 At the same time, the UPR causes the activation of 
the pro-apoptotic factor CHOP/GAD153, a member of the C/EBP family of transcription 
factors expressed at low levels under physiological conditions but strongly induced in 
response to different forms of stress. CHOP may lead to the activation of the mitochondrial 
pathway of apoptotic cell death for removal of the affected cell(s).7 
UPR is strictly connected to autophagy, a dynamic physiological process that triggers 
the self-digestion of damaged organelles and proteins. In stressed cells, autophagy can 
support cell adaptation and survival, but when protein and organelle turnover overwhelms the 
adaptive capacity, the cell dies. During development, autophagy may have additional 
important functions, including the adaptation to starvation occurring during fetal-to-neonatal 
transition.8 Autophagy also plays a role in inflammation and adaptive immune mechanisms 
by regulating the secretion of IL-1β and possibly other pro-inflammatory factors.9 Through 
these mechanisms, autophagy potentially influences disease pathogenesis. Strategies aimed at 
modulating the UPR and autophagy may lead to therapeutic interventions for diseases 
associated with inflammation, including brain injury. 
Melatonin (N-acetyl-5methoxytryptamine) is a versatile and ubiquitous molecule, well 
known as a potent indirect antioxidant and direct free radical scavenger.10 Melatonin has a 
pronounced protective effect in several models of perinatal brain damage attributed, at least 
in part, to its antioxidant and free radical scavenger properties.10 In addition, melatonin 
regulates energy metabolism11 and immune function12, acting as an immunostimulant under 
basal conditions and as an anti-inflammatory in the presence of an exacerbated immune 
response.12 Recently, we reported that melatonin protected neonatal rats from ischemic brain 
damage by reducing ER stress and preserving the expression of SIRT1, a nicotinamide 
adenine dinucleotide (NAD+)-dependent deacetylase.13 The latter effect appears to be of 
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particular relevance since enhanced SIRT1 activity has been found to protect against various 
neurodegenerative disorders14 and to inhibit NF-kB signaling and NF-kB-dependent pro-
inflammatory gene expression (i.e. IL-β).15  
SIRT1 expression and inflammatory pathways are also modulated by microRNAs 
(miRNAs), small non-coding RNAs (18-24 nucleotide long), a new paradigm of post-
transcriptional gene expression. MicroRNAs are able to modulate gene expression by 
targeting mRNA and suppressing protein expression. Single miRNAs can simultaneously 
regulate a multitude of targets and biological networks and have been linked to all known 
fundamental biological pathways. Deregulation of miRNAs may contribute to the 
development of human diseases.16 Among the various miRNAs, miR-34a was found to 
inhibit the expression of SIRT1 by repressing the translation process,17 whereas miR-146a 
and miR-126 have been associated to the regulation of inflammatory processes. 
Inflammation-related targets of miR-146a include IL-1 receptor-associated kinase-1 
(IRAK1), TNF receptor-associated factor 6 (TRAF6) and IL-1β. MiR-126 regulates the 
expression of vascular adhesion molecules and is implicated in ER stress expression since it 
can modulate the heat stress protein Hsp70.18  
In the present study, we investigated the effects of maternally administered melatonin 
on LPS-induced brain cellular stress. We report here that maternal lipopolysaccharide (LPS) 
sensitizes the immature rat brain to a second postnatal excitotoxic injury. Furthermore, we 
show that LPS induces a brain inflammatory response at postnatal day-1 (PND1) associated 
with modulation of UPR, autophagy and miR-34a/SIRT-1 pathway. Melatonin completely 
reverted the LPS effects. 
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2 | METHODS 
 
2.1 | Animals and drugs  
All experimental procedures were carried out in compliance with the European Community 
Commission directive guidelines (86/609/EEC) and have been approved by the “Val de 
Loire” ethical committee (n°00022.01). Time-pregnant Wistar rats were purchased from 
CERJ (Le Genest, France). They had free access to food and water and were bred at 22°C 
with a normal light cycle. LPS (E. coli, serotype 055:B5; Sigma-Aldrich, MO, USA) was 
diluted in saline (LPS vehicle), and was injected intraperitoneally (i.p.) at the dose of 300 
μg/kg to pregnant rats at gestational day (GD) 19 and 20. Melatonin was dissolved in saline 
containing 2% ethanol (melatonin vehicle), and injected i.p. at the dose of 5 mg/kg to 
pregnant rats at GD19 and GD20, in the opposite abdominal side to LPS injections.  
The experiment included the following experimental groups: 1) LPS and melatonin vehicle-
treated controls (Control); 2) Melatonin 5 mg/kg and LPS vehicle (Mel); 3) LPS 300 μg/kg 
and melatonin vehicle (LPS); 4) LPS 300 μg/kg plus melatonin 5 mg/kg (LPS+Mel). 
 
2.2 | Ibotenate-induced excitotoxic lesions 
Ibotenate (Tocris, Bristol, UK), a glutamate agonist, was diluted in PBS containing 0.02% 
acetic acid and was injected at post natal day (PND) 4 in pup brains under anesthesia. Twelve 
pups were provided for each experimental group. As previously described,19-20 injections 
were performed under a warming lamp with a 26-gauge needle on a 50-μl Hamilton syringe 
mounted on a calibrated microdispenser. The needle was inserted 2 mm under the external 
surface of the scalp skin in the fronto-parietal area of the right hemisphere, 2 mm from the 
midline in the lateral–medial plane and 3 mm from the junction between the sagittal and 
lambdoid sutures in the rostrocaudal plane. Two 1 μl boluses (5 µg of ibotenate) were 
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injected at a 30 second interval. In all cases, the tip of the needle reached the periventricular 
white matter. After the injections, the pups were returned to their dams. 
At PND8, animals were sacrificed by decapitation. Brains were rapidly removed from the 
skull and immersed in a 4% formaldehyde solution for 4 days at room temperature. After 
dewatering in successive baths of 100% ethanol and xylene for 24 hours, brains were 
embedded in paraffin and 16-µm thick coronal sections were performed. The maximal 
diameter in the sagittal axis of the lesion was measured on histological sections stained with 
cresyl violet, distinguishing cortical and white matter levels. Lesion size was determined by 
two independent investigators, blind with respect to the treatment status of the animal from 
which tissue had been taken.  
 
2.3 | Immunofluorescence staining 
Newborn rats were sacrificed at PND1 by decapitation, 48 hours after the last i.p. maternal 
injections. Brains were quickly removed from the skull and were post-fixed in 4% 
paraformaldehyde overnight at 4°C. After 2 days in 10% sucrose- 0.12M phosphate buffer 
solution, brain was embedded in a cooled 10% sucrose - 7.5% gelatin solution before 
freezing. Finally, brains were cut coronally in 10 µm-thick sections. 
The following primary antibodies were used for immunostainings: Anti-Iba-1 (Rabbit, 
1:2000, Wako, 019-197414), Anti- inducible NO synthase (iNOS) (Mouse, 1:200, BD 
Transduction Laboratories, 610328) and Anti- Cleaved Caspase-3 (CC3) (Rabbit, 1:300, Cell 
Signaling Technology, #9661). 
The buffer for the antibody dilution contained 1X PBS with 1% donkey or goat serum 
according to secondary antibody plus 0.4% Triton X-100 to permeabilize cell membrane. 
After 3 rinses in 1X PBS, the antigen blocking was performed with 5% serum for 45 min. 
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Then, the primary antibody was incubated overnight at room temperature. The second day, 
the appropriate secondary antibody was applied for 90 min (1:500 dilution for the Cy3 and 
Alexa 488 secondary antibodies). A counterstain by DAPI (1:10000, Sigma-Aldrich, MO, 
USA) labeling the nucleus was performed at the end of immunofluorescence protocol. 
After the immunofluorescent staining procedure, pictures at magnification 20 focusing on 
cingulum were performed in each experimental group (N=5 brains/ group). Cingulum region 
was chosen because of its particular richness in microglia at this brain developmental stage.21 
Pictures were analyzed with NIH Image J software.  
 
2.4 | Western blot analysis 
Newborn rats were sacrificed at PND1 by decapitation, 48 hours after the last i.p. maternal 
injections. Brains were dissected on ice, frozen in isopentane cooled to –35°C with dry ice, 
and stored at –80°C until use. 
Brains were sonicated in 0.4 mL lysis buffer containing 10 mM Tris, 10 mM EDTA, 1 mM 
EGTA, 0.1 mM phenylmethylsulfonyl fluoride and a complete protease inhibitor cocktail 
(Roche, 1 697 498) using an Ultrasonic Liquid Processor XL Sonicator (Heat 
SystemUltrasonic Inc.). Homogenates were centrifuged for 5 min at 18,500g (4°C) and the 
supernatants aspirated and stored at -80°C until used. After mixing with sodium dodecyl 
sulfate gel-loading buffer and heating 4 min at 95°C, samples (50 μg protein) were 
electrophoresed onto sodium dodecyl sulfate-polyacrylamide gel and proteins transferred to a 
PVDF membrane. ColorBurstTM electrophoresis marker (3 μL/gel, Sigma, C1992) was used 
for qualitative molecular mass determinations and for visual confirmation of blot transfer 
efficiency. Blots were then blocked with non-fat dry milk in TBS-T (10 mM Tris, 150 mM 
NaCl, pH 7.6, plus 0.1% Tween-20) and probed with the following primary antibodies: anti-
CHOP (1:500, monoclonal; Santa Cruz Biotecnology, sc-7351); anti phospho(p)-eIF2α 
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(1:500, monoclonal; Santa Cruz Biotecnology, sc-101670); anti-GRP78 (1:500, monoclonal; 
Santa Cruz Biotecnology, cs-166490); anti-Hsp70/Hsc70 (1:500, monoclonal; Santa Cruz 
Biotecnology, sc-24); anti-LC3 (1:1000, polyclonal; Cell Signaling Technology, #2775); anti-
Beclin 1 (1:500, monoclonal; BD Transduction Laboratories, 612113); anti-p62 (1µg/mL, 
polyclonal; Sigma-Aldrich, P0067); anti-SIRT1 (1:1000, polyclonal; Santa Cruz 
Biotecnology, sc-15404). A monoclonal antibody against β-actin (1:4000, Santa Cruz 
Biotechnology, sc-8432) was used as control for protein gel loading. The relative intensity of 
the bands detected by Western blot was analyzed using Image J 1.45 software. Data were 
normalized to β-actin and expressed as percent of control. 
 
2.5 | Quantitative Real Time PCR (qRT-PCR) for mature microRNAs analysis 
We used the mirVana isolation kit (Applied Biosystems, Foster City, CA) following 
the manufacturer’s recommended protocol to isolate microRNAs from the same brain 
homogenate supernatants used for western blot analysis. RNA was stored at -80 °C until use. 
Rat miR-34a, miR-126, miR-146a and U6 (reference miRNA) expressions were evaluated by 
using the TaqMan MicroRNA assay (Applied Biosystems). The TaqMan MicroRNA reverse 
transcription kit was used to reverse transcribe microRNA. Subsequently RT-qPCR was 
performed in 20 μL of PCR mix containing 1 μL of 20x TaqMan MicroRNA assay, which 
contained PCR primers and probes (5′-FAM), 10 μL of 2x TaqMan Universal PCR Master 
Mix No Amp Erase UNG (Applied Biosystems) and 5 μL of reverse-transcribed product. The 
reaction was first incubated at 95 °C for 10 min followed by 40 cycles at 95 °C for 15 s and at 
60 °C for 1 min. The qRT-PCR was performed on a ABIPRISM 7500 Real Time PCR 
System (Applied Biosystems). Data were analyzed by a 7500 system software (1 1.4.0) with 
the automatic comparative threshold (Ct) setting for adapting baseline. Detection thresholds 
were set at 35 Ct. The relative amounts of miR-34a, miR-146a and miR-126 were calculated 
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using the Ct method: 
 ΔCt = Ct(miR-34a/miR-146a/miR-126) − Ct(U6); 2ΔCt 
Results are expressed in the figures as fold induction relative to control values. 
 
2.6 | Data analysis 
Statistical analyses were performed by One-way ANOVA using the Prism Computer 
program (GraphPad Software Inc.). The Newman-Keuls multiple comparison test was used to 
determine differences between single treatment groups. P<0.05 was considered significant. 
 
 
3 | RESULTS 
 
3.1 | Melatonin effect on a second ibotenate-iduced excitotoxic insult at PND4  
To assess the conditioning or sensitizing effect of prenatal LPS challenge and the 
potential modulating effect of melatonin, a second excitotoxic insult consisting in an 
intracranial injection of ibotenate, a glutamatergic agonist, was performed at PND4. Prenatal 
exposure to LPS led to a significant increase in cortical and white matter lesion size reflecting 
the sensitizing effect of inflammatory challenge in our model (Fig.1; p<0.05 in comparison 
with the control group). When melatonin was associated with LPS, cortical and white matter 
lesion size was the same as in the control group (Fig.1). This result suggests that melatonin 
prevented the sensitizing effect of inflammation to a second insult on neonatal brain. 
Surprisingly, prenatal melatonin injections exhibited a neuroprotective effect exclusively on 
white matter out of the inflammatory context (Fig. 1; p<0.05 in comparison with the control 
group). 
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3.2 | Melatonin effect on microglial activation induced by LPS at PND1  
Prenatal LPS injections induced a significant increase in Iba-1 positive cells within 
cingulum at PND1 (Fig. 2B). Iba-1 positive cells showed an amoeboid aspect reflecting the 
microglia activated state (Fig. 2A). In parallel, inducible NO synthase (iNOS) staining, 
indicating a pro-inflammatory process and acute microglial activation, was increased 
following the same pattern as the Iba-1 staining (Fig. 2C and D). Therefore, our prenatal 
inflammatory challenge led to significant microglia activation at PND1. 
Prenatal melatonin injections at the same time as LPS injections induced a reduction 
in Iba-1 and iNOS stainings within cingulum at PND1 in comparison with pups only treated 
with LPS (Fig. 2A-D). Surprisingly, Iba-1+ and iNOS+ cells were less numerous in rats 
exposed to melatonin even without LPS challenge (Fig. 2A-D). Thus, prenatal melatonin 
showed a strong anti-inflammatory effect on neonatal brain whatever the inflammatory status 
was. 
 
3.3 | LPS and melatonin effect on ER stress, autophagy and apoptosis  
To examine whether maternal LPS caused ER stress in the neonatal brain, we assessed 
the expression of proteins involved in the UPR. As shown in Figure 3, LPS significantly 
induced the expression of CHOP, a member of the CCAAT/enhancer-binding protein family 
of transcription factors that is over-expressed following disruption of ER homeostasis22 (Fig. 
3A), and the phosphorylation of eIF2α (Fig. 3B), which leads to inhibition of translation in 
the ER.23 LPS also increased the expression of Hsp70 (Fig. 3C), which is normally up-
regulated during ER stress.24 Surprisingly, GRP78, a member of the HSPs protein family 
resident in the ER and generally up-regulated after ER stress, was not increased (Fig. 3D). 
Maternal melatonin administration completely reverted the effects of LPS on ER stress 
proteins (Fig. 3A, B and C). 
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Since the UPR response is strictly connected to autophagy,25-26 we also studied the 
autophagy process. LPS caused a significant reduction in both lipidated LC3 (LC3 II, Fig. 
4A), a microtubule-associated protein that is lipidated upon activation of autophagy, and 
beclin 1 (Fig. 4B), a component of the PI3K complex that is required for autophagosome 
formation. The effect of LPS on autophagy activation was also confirmed by the increased 
expression of p62 (Fig. 4C), a protein degraded during the autophagy process that serves to 
link ubiquitinated proteins to the autophagy machinery.27 Melatonin blocked the effect of 
LPS and restored the expression of autophagy proteins to control values (Fig. 4).  
To study the implication of apoptosis in LPS pathogenesis at PND1, we assessed 
cleaved-caspase-3 (CC3), a well-known apoptosis marker. CC3-stained cell number was not 
modified within cingulum at PND1 by prenatal exposure to LPS in comparison with control 
rats. Melatonin by itself induced a reduction in brain apoptosis at PND1. This effect was 
observed in both control and LPS-treated groups (Fig. 5 A and B). This result does not argue 
for an implication of apoptosis pathway in inflammation challenge pathogenesis in our 
model. Melatonin, as previously shown,28 demonstrated an anti-apoptotic property.  
 
3.4 | The effect of melatonin and LPS-induced inflammation on SIRT-1 and related 
miRNA  
Since SIRT1 has been implicated in the neuroprotective effect of melatonin after 
ischemia,13 we investigated if this sirtuin could also be involved in this model of prenatal 
inflammation. As shown in Figure 6, LPS significantly reduced the expression of SIRT1 on 
pups and this effect was completely reverted by melatonin. 
We also investigated the modulation of miRNAs targeting IL1β, Hsp70 and SIRT1, 
i.e miR-146a, miR-126 and miR-34a, respectively. MiR146a (Fig. 7A) and miR126 (Fig. 7B) 
were significantly decreased in pups prenatally treated with LPS, effects that were completely 
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blocked by melatonin (Fig. 7A and B). Interestingly, miR-34a expression, that has been 
demonstrated to directly target SIRT-1, was significantly increased after LPS and reduced by 
melatonin (Fig. 7C).  The modulation pattern of these miRNAs clearly matched the pattern of 
the respective target proteins (Fig. 3C and  Fig. 6, respectively).29 
 
4 | DISCUSSION 
        Epidemiologic and experimental findings implicate maternal infection/inflammation in 
the etiology of brain injury in preterm newborns.30 Here we show that maternal infection 
during late gestation and the subsequent fetal inflammation, mimicked by LPS injection, 
cause a pro-inflammatory state on PND1 characterized by induction of ER stress, reduction 
of autophagy and SIRT1 expression, modulation of related miRNAs, and sensitization to a 
second excitotoxic brain damage. The most important finding of the present study, however, 
is that melatonin administration at the same time as LPS completely reverts these effects. 
 
4.1 | The beneficial effect of melatonin in the inflammatory context 
          Melatonin action has been mainly explored in hypoxic-ischemic animal models. Here, 
a prenatal pro-inflammatory challenge mimicking the chorioamnionitis context was used. Our 
results demonstrate that the placental barrier was insufficient to prevent the deleterious 
effects of systemic maternal inflammation/infection on the fetal brain as well as the 
modulating effect of melatonin. A modulating effect of melatonin on microglia activation 
was also recently reported in PND5 rats receiving i.p. LPS.31 In addition, in keeping with our 
data, a protective effect of melatonin associated with a reduced iNOS activity was recently 
reported in heart mitochondrial impairment during sepsis.32 Interestingly, the beneficial effect 
of melatonin on the neonatal brain was also independent on the inflammatory context, as 
shown by the reduction of the white matter damage after an ibotenate-induced excitotoxic 
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challenge. This finding is in keeping with previous data showing a strong protective effect of 
melatonin on the white matter after intracranial ibotenate injection. Blocking the cAMP 
pathway through melatonin was implicated in this effect.19 A sensitizing effect of 
inflammation in the ibotenate model was also shown after interleukine-1β i.p. injections to 
mouse pups.33 These findings may argue for pleiotropic actions of melatonin and support its 
remarkable neuroprotective effect in various noxious contexts.  
 
4.2 | Implication of ER stress, autophagy, SIRT-1, and related miRNA, in the 
neuroprotective action of melatonin 
Maternal LPS exposure during pregnancy was reported to induce ER stress in the 
placenta and contribute to intrauterine fetal growth restriction and death.34  In our 
experimental model, LPS caused ER stress in the neonatal brain, as indicated by the increased 
expression of CHOP and Hsp70, and by the increased phosphorylation of eIF2α. In contrast 
to the clear indication of UPR after LPS, we observed no increase in the expression of the 
molecular chaperon GRP78. Among the Hsp70 protein family, GRP78 is manly localized in 
the ER and is generally up-regulated during glucose deprivation-induced ER stress following 
an ischemic insult.26,35-36 Hsp70 and its constitutive form Hsc70, manly localized in the 
cytosol and in the nucleus, are involved in chaperoning processes, including refolding of 
misfolded or aggregated proteins. Hsp70 is induced in response to a variety of stressful 
stimuli (e.g., ischemia, hyperthermia, oxidative stress and mechanical stress)37-39 in all living 
organisms.  Hsp70 is implicated in the formation of the immunogenic complex40 as well as in 
the facilitation of the immune response to proteins and peptides, both in vivo and in vitro.41-42 
We hypothesize that the lack of activation of GRP78 and the marked activation of Hsp70 
may be functional for the cellular response in inflammatory conditions. This finding indicates 
that different cellular pathways may be activated during different stresses depending on the 
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eliciting stimuli (i.e. inflammatory versus oxygen/glucose deprivation conditions). Other 
factors may also condition the response including the intensity and duration of stress, the cell 
type, and environmental factors.  
Another important finding of the present study is the modulation of autophagy in 
fetal/neonatal brain inflammation and after melatonin administration. Autophagy is an 
intracellular bulk degradation process, fundamental for the quality and quantity regulation of 
key intracellular biological functions.43 Autophagy is in a dynamic equilibrium in the cell and 
its impairment can lead to metabolic dysfunctions and cell death. Autophagy is activated soon 
after birth in neonatal tissues and is essential for development and survival.8 Aminoacids 
produced by autophagy recycling peroxidized proteins can be used as an energy source or, 
alternatively, for the synthesis of new proteins for an appropriate response to starvation, a 
condition that neonates face at birth.44 We found that maternal inflammation significantly 
reduces autophagy in the neonatal brain, as indicated by the reduction of both beclin 1 and 
LC3 II expression and the increased p62 protein level. Growing evidence links defective 
autophagy to the pathogenesis and progression of several inflammatory diseases. Autophagy 
inhibition has been observed in cystic fibrosis-induced lung inflammation.45 A defective 
autophagy caused cytoplasmic accumulation of mutant SOD1 and enhanced the progression 
of the neurodegenerative amyotrophic lateral sclerosis.46 Conversely, autophagy activation 
showed cell protection in different types of metabolic, infectious, or inflammatory stresses.47-
48
 Autophagy can also support apoptosis and delay necrosis in neonatal hypoxia-ischemia.49-51 
Here we found a reduced autophagy that likely represents a lack of adaptation to events, such 
as birth, that may require a fully efficient autophagy machinery.8 The reduced autophagy may 
likely contribute to the functional consequences of the inflammatory process. Interestingly, 
here we found that melatonin completely reversed the effect of LPS on autophagy, in 
agreement with the clear link between inflammation and mitophagy, a selective form of 
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autophagy that was recently demonstrated in the protective effect of melatonin in traumatic 
brain injury.52 Whether or not mitophagy is involved in the inflammatory reaction induced by 
LPS needs to be determined. 
Autophagy and apoptosis are both programmed cell death processes which beclin-1 
represents a crosstalk. Caspase-3 would induce beclin-1 cleavage leading to autophagy 
reduction.53 In our model, we found that LPS injections do not affect apoptotic cell death 
through cleaved-caspase 3 staining. This result does not support the apoptosis-induced 
autophagy regulation in an inflammatory context.  Melatonin, conversely, exerts an 
antiapoptotic effect both in controls and in animals treated with LPS. The antiapoptotic effect 
of melatonin has been reported in several neurodegenerative conditions and may be the result 
of events occurring upstream to the activation of the intrinsic pathway of apoptosis, including 
its scavenging effect on reactive oxygen species28 and modulation of ER stress and 
autophagy.54  
An important factor involved in the protective effect of melatonin is SIRT1. Here we 
found that SIRT1 expression was markedly reduced after LPS. Melatonin completely 
reverted this reduction in agreement with our previous results obtained after hypoxia-
ischemia-induced brain damage in neonates13 and the results of other authors working with 
adult rats.36 We also found that this effect was concomitant with the recovery of the 
autophagy process. SIRT1 is a NAD+-dependent deacetylase involved in a wide variety of 
biological functions. Its activation triggers transcriptional programs that enhance metabolic 
efficiency, upregulate mitochondrial oxidative metabolism, and increase the resistance to 
oxidative stress by increasing antioxidant pathways and facilitating DNA and protein repair. 
SIRT1 also regulates the extension of the inflammatory response55 and the autophagy 
process.56 The reduction of inflammation by SIRT1 is obtained by controlling the acetylation 
of the nuclear factor kappa B (NF-κB);57  its ablation in macrophages results in NF-κB 
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hyperacetylation, increasing the transcriptional activation of proinflammatory target genes.58 
Increasing SIRT1-mediated NF-κB deacetylation has been proposed as a novel approach to 
inflammation.57  
Melatonin is an important regulator of immune response and seems to act as a 
stimulant under basal or immunosuppressive conditions and as an anti-inflammatory in the 
presence of an exacerbated immune response.12 In keeping with this dual effect of melatonin, 
a recent study by Volt et al.59 showed that chronic low doses of melatonin can counteract 
inflammaging, whereas high acute doses can counteract sepsis. Our results showing a reduced 
brain inflammatory response after a pharmacological dose of melatonin are in line with these 
findings. Melatonin also preserves NAD+ levels, contributing to the regulation of SIRT1 
expression and activity.60 The clock genes Bmall/Clock and their transcriptional regulators 
RORα and Rev-Erba,61-62 that control the expression of NF-kB and of the nicotinamide 
phosphoribosyltransferase, that represent the rate-limiting enzyme for NAD+ biosynthesis 
from nicotinamide, may be involved in this effect.63-64   
To further investigate the effects of LPS and melatonin in perinatal inflammation, we 
extended our experiments to the assessment of some miRNA related to inflammation and 
SIRT1. miR-146a was reduced by LPS and reverted to control values by melatonin. Among 
the validated inflammation-related targets of miR-146a, there are IL-1 receptor-associated 
kinase-1 (IRAK1), TNF receptor-associated factor 6 (TRAF6) and IL-1β. These targets are 
all involved in the processes discussed in this study: IRAK1 regulates TLR4 signaling; 
TRAF6-mediated NF-kB signaling requires the p62 protein to contribute to the autophagy 
machinery;65 and IL-1β actively participates in inflammation. MiR-126, which shows the 
same expression pattern as miR-146a, modulates either the inflammation process by 
regulating vascular adhesion molecule expression, and modulates ER stress by Hsp70 
expression. Its modulation by LPS and melatonin indicates a clear association to the target 
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protein. The same miRNAs-target association was observed when we analyzed miR-34a. 
Several reports have shown that miR-34a regulates cell cycle progression, cellular senescence 
and apoptosis and that it also plays important roles in neuronal development.66 Members of 
the miR-34 family have been implicated in brain trauma and epilepsy. MiR-34a inhibits 
SIRT1 and also regulates p53 dependent apoptosis through deacetylation and stabilization of 
p53.67 The clear modulation of miR34a and SIRT1 by LPS and melatonin observed in our 
study and the multiplicity of effects controlled by SIRT1 strongly suggest a pivotal role of 
this pathway in neuroprotection and inflammation related diseases of the neonate. 
 
5 | Conclusion 
This study provides further preclinical evidence of the neuroprotective effects of 
melatonin in inflammation-related brain injury. There is a strong association among maternal 
infection/inflammation, brain damage and severe/permanent neurodevelopmental handicaps 
in newborns. The present data clearly indicate that melatonin may represent an effective 
prophylactic/therapeutic protective strategy in the perinatal clinical setting. Clinical studies 
using melatonin in newborns have already shown promising results,68-70 and others are in 
progress.71 In addition, women with premature rupture of membranes who are hospitalized 
for a long time before birth and are positive for chorioamnionitis, as well as women 
presenting an imminent delivery in the chorioamnionitis context could benefit from 
melatonin. Of course, the safety of melatonin during pregnancy needs to be assessed.   
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FIGURE LEGENDS 
FIGURE 1 Effect of prenatal LPS-induced sensitization and melatonin on a second 
ibutenate-induced excitotoxic brain injury. Pregnant rats received LPS (300 μg/kg, i.p.) at 
gestational day (GD) 19 and 20 or LPS followed by 5 mg/kg melatonin (LPS+Mel). Control 
groups received saline (Control) or 5 mg/kg melatonin (Mel). Intracranial injection of 
ibotenate was performed on postnatal day (PND) 4 and rats sacrificed on PND8.  Brain lesion 
sizes were measured in cerebral cortex and white matter. Results are reported as mean ± 
S.E.M. (N=12). * p<0.05, compared to the Control group, § p<0.05 compared to the LPS 
group, One-way ANOVA followed by Newman-Keuls Multiple Comparison Test. 
 
FIGURE 2  Effect of prenatal LPS and melatonin on microglia activation within cingulum 
48 hours after the last maternal i.p. injection (PND1). Melatonin demonstrated a remarkable 
anti-inflammatory action in both control and LPS-exposed rat brain. Immunofluorescent 
stainings of Iba-1+ (A) and iNOS+ (C) cells, reflecting microglial cells and acute 
inflammatory activation respectively, were performed on pup brain at PND1. Iba-1+ (B) and 
iNOS+ (D) cells were counted within cingulum on 10 µm- thick coronal sections at 
magnification 20 in each experimental group (Control, Mel, LPS and LPS+Mel; N=5 
rats/group) (scale bar= 100 µm). Results are expressed in cells/mm² and means ± S.E.M. * 
indicates statistically significant difference from Control bar (* p<0.05) and § indicates 
statistically significant difference from LPS bar (§ p<0.05 and §§ p<0.01) in One-way 
ANOVA followed by Newman-Keuls Multiple Comparison Test. 
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FIGURE 3  Effect of prenatal LPS and melatonin on endoplasmic reticulum (ER) stress 
markers. Western blots and quantitative evaluation of CHOP (A), phospho-eIF2α (p-eIF2α, 
B), Hsp70 (C) and GRP78 (D) expression, reflecting ER stress, have been performed in 
PND1 pup brain of each experimental group (Control, Melatonin, LPS, LPS+Melatonin; N=5 
rats/group). β-actin was run as loading control. Results are reported as % of control and are 
the mean ± S.E.M . ** p<0.01 compared to the Control group, One-way ANOVA followed 
by Newman-Keuls Multiple Comparison Test. 
 
FIGURE 4 Effect of prenatal LPS and melatonin on the pup brain autophagy process at 
PND1. Representative Western blots and quantitative evaluation of lipidated LC3 (LC3 II, 
A), beclin 1 (B) and p62 (C) expression in neonatal brain. β-actin was run as loading control. 
Results are reported as % of control and are the mean ± S.E.M. (N=5). * p<0.05 compared to 
the Control group, One-way ANOVA followed by Newman-Keuls Multiple Comparison 
Test. 
 
FIGURE 5 Effect of prenatal LPS and melatonin on apoptosis within cingulum at PND1. A) 
Immunostaining of Cleaved-Caspase 3 (CC3), an apoptotic marker, was performed on frozen 
10 µm- thick sections from PND1 brain of each experimental group (Control, Mel, LPS, 
LPS+Mel; N=5 per group). B) CC3+ cell number was obtained from pictures taken at 
magnification 20 focusing on cingulum (Scale bar= 100 µm). Results are expressed in 
cells/mm² and means ± SEM. * indicates statistically significant difference from Control bar 
(* p<0.05 and ** p<0.01) and § indicates statistically significant difference from LPS bar (§ 
p<0.05) in One-way ANOVA followed by Newman-Keuls Multiple Comparison Test. 
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FIGURE 6 Effect of prenatal LPS and melatonin on SIRT1 expression in PND1 pup brain. 
Representative Western blots and quantitative evaluation of SIRT1 expression in neonatal 
brain. β-actin was run as loading control. Results are reported as % of control and are the 
mean ± S.E.M. (N=5). ** p<0.01 compared to the Control group, One-way ANOVA 
followed by Newman-Keuls Multiple Comparison Test. 
 
FIGURE 7 Effect of prenatal LPS and melatonin on microRNAs (miRNAs) expression. 
Relative expression analysis of miRNA-146a (A), miRNA-126 (B) and miRNA-34a (C) in 
neonatal PND1 brain performed by qRT-PCR. Results are reported as fold induction related 
to control values and are the mean ± S.E.M. (N=5). ** p<0.01 compared to the Control 
group, One-way ANOVA followed by Newman-Keuls Multiple Comparison Test. 
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